Institution
Tokyo Medical University Hachioji Medical Center
JPhealthcare
Recent research
- Health & MedicineOpen access
Macular leakage (ML) is a biomarker of disease activity and, in retinal vein occlusion (RVO), is associated with poor vision outcomes. Faricimab, a dual angiopoietin-2 (Ang-2)/vascular endothelial growth factor (VEGF)-A inhibitor, has demonstrated efficacy and durability in RVO....
- Health & MedicineOpen access
Abstract Background Platinum-based chemotherapy remains the cornerstone treatment for advanced urothelial carcinoma (aUC). However, treatment selection is often influenced by baseline renal function. Gemcitabine plus carboplatin (GCa) is widely used in patients who are considered...